Evaxion A (EVAX) Interest Coverage Ratio (2020 - 2026)
Evaxion A's (EVAX) quarterly Interest Coverage Ratio came in at 12.58 in Q1 2026, up 29.13% YoY from 9.74 in Q1 2025, and up 287.51% on a QoQ basis from 3.25 in Q4 2025.
Evaxion A (EVAX) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Evaxion A (EVAX) has 7 years of Interest Coverage Ratio data on file, last reported at 12.58 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 29.13% year-over-year to 12.58 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.08 (down 51.99% YoY) and the FY2025 annual result came in at 1.61, down 65.87% from the prior year.
- Interest Coverage Ratio improved to 12.58 in Q1 2026, from 3.25 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 40.5 in Q1 2022 to a low of 2.2 in Q3 2025.
- A 5-year average of 13.31 and a median of 11.06 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio jumped 178.44% — and 2025, when it tumbled 148.8%.
- Tracing EVAX's Interest Coverage Ratio over 5 years: stood at 11.06 in 2022, then sank by 55.91% to 4.88 in 2023, then surged by 80.19% to 8.79 in 2024, then slumped by 63.05% to 3.25 in 2025, then soared by 287.51% to 12.58 in 2026.
- The last three Interest Coverage Ratio figures came in at 12.58 (Q1 2026), 3.25 (Q4 2025), and 2.2 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Evaxion A | 26.86 Mn | 26.86 Mn | - | 12.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.58 |
| Dec 31, 2025 | 3.25 |
| Sep 30, 2025 | -2.20 |
| Jun 30, 2025 | 1.74 |
| Mar 31, 2025 | 9.74 |
| Dec 31, 2024 | 8.79 |
| Sep 30, 2024 | 4.51 |
| Jun 30, 2024 | 2.25 |
| Mar 31, 2024 | 17.87 |
| Dec 31, 2023 | 4.88 |
| Sep 30, 2023 | 31.66 |
| Jun 30, 2023 | 20.42 |
| Mar 31, 2023 | 20.02 |
| Dec 31, 2022 | 11.06 |
| Sep 30, 2022 | 11.37 |
| Jun 30, 2022 | 27.82 |
| Mar 31, 2022 | 40.50 |
| Dec 31, 2021 | 107.24 |
| Sep 30, 2021 | 21.49 |
| Jun 30, 2021 | 15.41 |